Know Cancer

or
forgot password


Phase 4
18 Years
N/A
Open (Enrolling)
Male
Prostatic Neoplasms, Adenocarcinoma

Thank you

Trial Information


Inclusion Criteria:



- Biopsy proven adenocarcinoma of the prostate

- Deemed a surgical candidate for a bilateral nerve bundle preservation

- Potent

- Continent of urine

- Surgical candidate for both open and robotic nerve-sparing radical prostatectomy

- Age >18

Exclusion Criteria:

- Previous treatment of prostate cancer (radiation, hormones, etc.)

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Trifecta

Outcome Description:

Free from biochemical recurrence, continent, and potent 2 years after radical prostatectomy

Outcome Time Frame:

at 2 years

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

IRB# 11-002288

NCT ID:

NCT01365143

Start Date:

May 2011

Completion Date:

May 2016

Related Keywords:

  • Prostatic Neoplasms
  • Adenocarcinoma
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Neoplasms
  • Prostatic Neoplasms

Name

Location

Mayo ClinicRochester, Minnesota  55905